An FDA advisory panel voted to approve GRAIL's Galleri multi-cancer early detection test for adults 50+. Read key oncology nursing takeaways.
|Articles|November 28, 2014
NPF Fellows Symposium
We are pleased to open the application period for our annual Fellows Symposium.
Advertisement
We are pleased to open the application period for our annual Fellows Symposium.
CME credits and travel scholarships are available to physicians and PhD-level scientists who have demonstrated an interest in pancreatic disease.
The application and other information is available here:
Advertisement
Related to this article
Oncology nurse April Fowler shares her personal stage 4 cancer journey, reflecting on clinical empathy, patient advocacy, and oncology endurance.
Dr. Jason Konner discusses psilocybin, clinician burnout, CIPN prevention, and safety protocols for oncology nurses and care teams in cancer care.
Non-CME PER® Podcast
FDA approves belzutifan with lenvatinib for advanced clear cell RCC after PD-1/PD-L1 inhibitor failure. Review LITESPARK-011 data and nursing takeaways.
ANA President Jennifer Mensik Kennedy outlines systemic nurse fatigue mitigation policies, emphasizing patient safety and acuity across oncology care.
From ICN 2026, Heather Jackson and Ashley Johnson detail APP breast care access models, global cancer pain barriers, and burnout mitigation tactics.
FDA approves lirafugratinib (Lyrfigtu) for FGFR2+ cholangiocarcinoma. Review REFOCUS trial data, 70 mg daily dosing, and nursing safety guidelines.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Psychedelic Medicine in Cancer Care: What Nursing Teams Need to Know
2
Oncology Nurse Shares Insights From Her Stage 4 Breast Cancer Journey
3
Reframing Nurse Fatigue as Systemic Safety Risk
4
FDA Advisory Panel Votes to Approve GRAIL Galleri MCED Screening Test
5